Back
Evidence Summary
What is an Evidence Summary?
Key messages from scientific research that's ready to be acted on
Got It, Hide this
In people with diabetes, group medical visits reduce HbA1c levels more than usual care
Housden L, Wong ST, Dawes M. Effectiveness of group medical visits for improving diabetes care: a systematic review and meta-analysis. CMAJ. 2013;185:E635-44.
Review question
In people with type 1 or type 2 diabetes, do group medical visits improve patient outcomes more than usual care?
Background
People with diabetes are at higher risk than many other people to get cardiovascular disease (for example, heart attack or stroke).
Family doctors can help people with diabetes manage their cardiovascular risk factors, such as blood glucose levels, blood pressure, weight, body mass index, and cholesterol levels.
Most people meet with their family doctors one-on-one. In group medical visits, several people with the same disease meet with their doctor or nurse at the same time. Other health care workers, such as pharmacists or nutritionists, may also be at these visits.
How the review was done
The researchers did a systematic review, searching for studies that were published up to February 2012.
They found 13 randomized controlled trials with 2319 people and 13 nonrandomized trials with 3498 people. The key features of the randomized controlled trials were:
- People had type 1 or type 2 diabetes and were 16 to 80 years old.
- At group visits, people could get a health evaluation, information about their disease, prescriptions or referrals, or be sent for lab tests; they could also talk with other people with diabetes.
- Group medical visits were compared with usual care.
- The outcomes were glycated hemoglobin (HbA1c) levels, cardiovascular risk factors, and quality of life; they were measured at 4 months to 5 years after group visits started.
What the researchers found
These are the findings from the randomized controlled trials, which usually have higher quality results than nonrandomized trials.
Compared with usual care, group medical visits
- reduced HbA1c levels by an average of 0.46%, although the difference could be as little as 0.12% or as much as 0.80%. So if a person started out with a glucose level of 8.5%, on average that would drop to about 8%.
- were no better for reducing cardiovascular risk factors.
- did not improve quality of life.
Conclusion
In people with type 1 or type 2 diabetes, group medical visits reduce HbA1c levels more than usual care. They do not reduce cardiovascular risk factors or quality of life.
Group medical visits vs usual care
HbA1c | 0.46% less with group medical visits | As little as 0.12% to as much as 0.80% difference |
Glossary
Randomized controlled trials
Studies where people are assigned to one of the treatments purely by chance.
Risk factors
Aspects making a condition more likely.
Systematic review
A comprehensive evaluation of the available research evidence on a particular topic.
Vascular
The body's network of blood vessels. It includes the arteries, veins, and capillaries that carry blood to and from the heart.
Related Evidence Summaries
-
Journal of Diabetes Science and Technology (2018)
-
Cochrane Database of Systematic Reviews (2014)
-
Cochrane Database of Systematic Reviews (2012)
Related Web Resources
-
OHRI
This patient decision aid helps People with prediabetes considering treatment to help prevent type 2 diabetes decide on whether to make a major lifestyle change or take the medicine metformin by comparing the benefits, risks, and side effects of both options.
-
Harvard School of Public Health
There are three main types of fat: unsaturated, saturated and trans fat. Unsaturated fats can help improve cholesterol levels and lower inflammation and are found in olive oil, avocados, nuts, seeds and fish. Trans fats are common in fast foods, and can increase your risk of heart disease, stroke, diabetes and other chronic conditions.
-
Informed Health Online
Talk to your doctor about diabetes medications. Consider your treatment goals, age, weight, health conditions and other medications when deciding if a drug is right for you.
DISCLAIMER These summaries are provided for informational purposes only. They are not a substitute for advice from your own health care professional. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the McMaster Optimal Aging Portal
(
info@mcmasteroptimalaging.org).